Study Evaluating Multiple Ascending Dose in Schizophrenia Patients

NCT00620568 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SLV-313 SR

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]